Analysis of the clinicopathological characteristics, genetic phenotypes, and prognostic of pure mucinous adenocarcinoma

被引:18
作者
Chen, Zhencong [1 ]
Li, Ming [1 ]
Ma, Ke [1 ]
Shang, Guoguo [2 ]
Liang, Jiaqi [1 ]
Yin, Jiacheng [1 ]
Luo, Jizhuang [1 ]
Zhan, Cheng [1 ]
Shi, Yu [1 ]
Wang, Qun [1 ]
机构
[1] Fudan Univ, Dept Thorac, Zhongshan Hosp, Shanghai, Peoples R China
[2] Fudan Univ, Dept Pathol, Zhongshan Hosp, Shanghai, Peoples R China
基金
中国国家自然科学基金;
关键词
clinicopathological features; genetic analysis; nomogram; pure mucinous adenocarcinoma; the surveillance; epidemiology; and end results; CELL LUNG-CANCER; THYROID TRANSCRIPTION FACTOR-1; MUTATIONS; KRAS; CLASSIFICATION; EGFR; ASSOCIATION; POLYCOMB; EXPRESSION; PCGF6;
D O I
10.1002/cam4.2726
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background Primary pure mucinous adenocarcinoma of the lung (PMA) is a rare subtype. However, correlations between clinicopathological features and genetic phenotypes with survival have not been described comprehensively. Methods Pure mucinous adenocarcinoma patient information collected from the Surveillance, Epidemiology, and End Results (SEER) database, the Department of Thoracic Surgery, Zhongshan Hospital, Fudan University (FDZSH), and the Cancer Genome Atlas (TCGA) were extracted, evaluated, and compared with other lung adenocarcinomas (LUAD) patient data. Gene Ontology and Kyoto Encyclopedia of Genes and Genomes pathway analyses were performed to explore the functional importance of underlying molecular changes. Overall survival (OS) was evaluated with the Kaplan-Meier method. Univariate and multivariate analysis through Cox proportional hazard regression identified risk factors that predicted OS, and the results were used to construct a nomogram to predict OS for PMA patients. Results Overall, 3622 patients, 41 patients, and 15 patients with PMA were identified from the SEER, FDZSH, and TCGA databases, respectively. There were 345 differentially expressed genes, 30 differentially mutated genes and 72 differentially methylated genes were identified between PMA and other LUAD samples. In the SEER database, PMA had a better prognosis compared to other LUAD. Compared with patients with other LUAD, patients with PMA exhibited unique clinicopathological features, including fewer grade III/IV tumors, less pleural invasion, more early-stage cancer, and more lower lobe carcinomas. Multivariate analyses showed that age, race, T stage, N stage, surgery, and chemotherapy were independent risk factors. The nomogram had a calibration index of 0.724. Conclusions Our research identified unique clinicopathological characteristics and genetic phenotypes for PMA and other LUAD. The nomogram accurately predicted OS.
引用
收藏
页码:517 / 529
页数:13
相关论文
共 34 条
[31]   Prognostic value of visceral pleural invasion in non-small cell lung cancer: A propensity score matching study based on the SEER registry [J].
Yang, Xiaodong ;
Sun, Fenghao ;
Chen, Li ;
Shi, Mengkun ;
Shi, Yu ;
Lin, Zongwu ;
Feng, Mingxiang ;
Zhan, Cheng ;
Jiang, Wei ;
Wang, Qun .
JOURNAL OF SURGICAL ONCOLOGY, 2017, 116 (03) :398-406
[32]   Validation of the IASLC/ATS/ERS Lung Adenocarcinoma Classification for Prognosis and Association with EGFR and KRAS Gene Mutations Analysis of 440 Japanese Patients [J].
Yoshizawa, Akihiko ;
Sumiyoshi, Shinji ;
Sonobe, Makoto ;
Kobayashi, Masashi ;
Fujimoto, Masakazu ;
Kawakami, Fumi ;
Tsuruyama, Tatsuaki ;
Travis, William D. ;
Date, Hiroshi ;
Haga, Hironori .
JOURNAL OF THORACIC ONCOLOGY, 2013, 8 (01) :52-61
[33]   Pcgf6, a Polycomb Group Protein, Regulates Mesodermal Lineage Differentiation in Murine ESCs and Functions in iPS Reprogramming [J].
Zdzieblo, D. ;
Li, X. ;
Lin, Q. ;
Zenke, M. ;
Illich, D. J. ;
Becker, M. ;
Mueller, A. M. .
STEM CELLS, 2014, 32 (12) :3112-3125
[34]   Aberrant status and clinicopathologic characteristic associations of 11 target genes in 1,321 Chinese patients with lung adenocarcinoma [J].
Zhao, Mengnan ;
Zhan, Cheng ;
Li, Ming ;
Yang, Xiaodong ;
Yang, Xinyu ;
Zhang, Yong ;
Lin, Miao ;
Xia, Yifeng ;
Feng, Mingxiang ;
Wang, Qun .
JOURNAL OF THORACIC DISEASE, 2018, 10 (01) :398-+